Global Osteoporosis Therapeutics Industry

New York, Oct. 18, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Osteoporosis Therapeutics Industry" - https://www.reportlinker.com/p05817617/?utm_source=GNW
4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$6.7 Billion by the year 2025, Bisphosphonates will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 3% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$133.8 Million to the region’s size and clout in the next 5 to 6 years. Over US$107.4 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Bisphosphonates will reach a market size of US$371.4 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6% over the next couple of years and add approximately US$1 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, Allergan PLC; Allergan PLC; Amgen, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Merck KGaA; Novartis International AG; Novo Nordisk A/S; Pfizer, Inc.; Teva Pharmaceutical Industries Ltd.


Read the full report: https://www.reportlinker.com/p05817617/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Osteoporosis Therapeutics Competitor Market Share Scenario
Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Osteoporosis Therapeutics Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 2: Osteoporosis Therapeutics Global Retrospective Market
Scenario in US$ Million by Region/Country: 2009-2017
Table 3: Osteoporosis Therapeutics Market Share Shift across
Key Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Bisphosphonates (Drug Type) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 5: Bisphosphonates (Drug Type) Historic Market Analysis
by Region/Country in US$ Million: 2009 to 2017
Table 6: Bisphosphonates (Drug Type) Market Share Breakdown of
Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Parathyroid Hormone Therapy (Drug Type) Potential
Growth Markets Worldwide in US$ Million: 2018 to 2025
Table 8: Parathyroid Hormone Therapy (Drug Type) Historic
Market Perspective by Region/Country in US$ Million: 2009 to
2017
Table 9: Parathyroid Hormone Therapy (Drug Type) Market Sales
Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Calcitonin (Drug Type) Geographic Market Spread
Worldwide in US$ Million: 2018 to 2025
Table 11: Calcitonin (Drug Type) Region Wise Breakdown of
Global Historic Demand in US$ Million: 2009 to 2017
Table 12: Calcitonin (Drug Type) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 13: Selective Estrogen Inhibitors Modulator (SERM) (Drug
Type) World Market Estimates and Forecasts by Region/Country in
US$ Million: 2018 to 2025
Table 14: Selective Estrogen Inhibitors Modulator (SERM) (Drug
Type) Market Historic Review by Region/Country in US$ Million:
2009 to 2017
Table 15: Selective Estrogen Inhibitors Modulator (SERM) (Drug
Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS
2025
Table 16: Rank Ligand Inhibitors (Drug Type) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 17: Rank Ligand Inhibitors (Drug Type) Historic Market
Analysis by Region/Country in US$ Million: 2009 to 2017
Table 18: Rank Ligand Inhibitors (Drug Type) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Osteoporosis Therapeutics Market Share (in %) by Company:
2019 & 2025
Table 19: United States Osteoporosis Therapeutics Market
Estimates and Projections in US$ Million by Drug Type: 2018 to
2025
Table 20: Osteoporosis Therapeutics Market in the United States
by Drug Type: A Historic Review in US$ Million for 2009-2017
Table 21: United States Osteoporosis Therapeutics Market Share
Breakdown by Drug Type: 2009 VS 2019 VS 2025
CANADA
Table 22: Canadian Osteoporosis Therapeutics Market Estimates
and Forecasts in US$ Million by Drug Type: 2018 to 2025
Table 23: Canadian Osteoporosis Therapeutics Historic Market
Review by Drug Type in US$ Million: 2009-2017
Table 24: Osteoporosis Therapeutics Market in Canada:
Percentage Share Breakdown of Sales by Drug Type for 2009,
2019, and 2025
JAPAN
Table 25: Japanese Market for Osteoporosis Therapeutics: Annual
Sales Estimates and Projections in US$ Million by Drug Type for
the Period 2018-2025
Table 26: Osteoporosis Therapeutics Market in Japan: Historic
Sales Analysis in US$ Million by Drug Type for the Period
2009-2017
Table 27: Japanese Osteoporosis Therapeutics Market Share
Analysis by Drug Type: 2009 VS 2019 VS 2025
CHINA
Table 28: Chinese Osteoporosis Therapeutics Market Growth
Prospects in US$ Million by Drug Type for the Period 2018-2025
Table 29: Osteoporosis Therapeutics Historic Market Analysis in
China in US$ Million by Drug Type: 2009-2017
Table 30: Chinese Osteoporosis Therapeutics Market by Drug
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Osteoporosis Therapeutics Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Table 31: European Osteoporosis Therapeutics Market Demand
Scenario in US$ Million by Region/Country: 2018-2025
Table 32: Osteoporosis Therapeutics Market in Europe: A
Historic Market Perspective in US$ Million by Region/Country
for the Period 2009-2017
Table 33: European Osteoporosis Therapeutics Market Share Shift
by Region/Country: 2009 VS 2019 VS 2025
Table 34: European Osteoporosis Therapeutics Market Estimates
and Forecasts in US$ Million by Drug Type: 2018-2025
Table 35: Osteoporosis Therapeutics Market in Europe in US$
Million by Drug Type: A Historic Review for the Period
2009-2017
Table 36: European Osteoporosis Therapeutics Market Share
Breakdown by Drug Type: 2009 VS 2019 VS 2025
FRANCE
Table 37: Osteoporosis Therapeutics Market in France by Drug
Type: Estimates and Projections in US$ Million for the Period
2018-2025
Table 38: French Osteoporosis Therapeutics Historic Market
Scenario in US$ Million by Drug Type: 2009-2017
Table 39: French Osteoporosis Therapeutics Market Share
Analysis by Drug Type: 2009 VS 2019 VS 2025
GERMANY
Table 40: Osteoporosis Therapeutics Market in Germany: Recent
Past, Current and Future Analysis in US$ Million by Drug Type
for the Period 2018-2025
Table 41: German Osteoporosis Therapeutics Historic Market
Analysis in US$ Million by Drug Type: 2009-2017
Table 42: German Osteoporosis Therapeutics Market Share
Breakdown by Drug Type: 2009 VS 2019 VS 2025
ITALY
Table 43: Italian Osteoporosis Therapeutics Market Growth
Prospects in US$ Million by Drug Type for the Period 2018-2025
Table 44: Osteoporosis Therapeutics Historic Market Analysis in
Italy in US$ Million by Drug Type: 2009-2017
Table 45: Italian Osteoporosis Therapeutics Market by Drug
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 46: United Kingdom Market for Osteoporosis Therapeutics:
Annual Sales Estimates and Projections in US$ Million by Drug
Type for the Period 2018-2025
Table 47: Osteoporosis Therapeutics Market in the United
Kingdom: Historic Sales Analysis in US$ Million by Drug Type
for the Period 2009-2017
Table 48: United Kingdom Osteoporosis Therapeutics Market Share
Analysis by Drug Type: 2009 VS 2019 VS 2025
SPAIN
Table 49: Spanish Osteoporosis Therapeutics Market Estimates
and Forecasts in US$ Million by Drug Type: 2018 to 2025
Table 50: Spanish Osteoporosis Therapeutics Historic Market
Review by Drug Type in US$ Million: 2009-2017
Table 51: Osteoporosis Therapeutics Market in Spain: Percentage
Share Breakdown of Sales by Drug Type for 2009, 2019, and 2025
RUSSIA
Table 52: Russian Osteoporosis Therapeutics Market Estimates
and Projections in US$ Million by Drug Type: 2018 to 2025
Table 53: Osteoporosis Therapeutics Market in Russia by Drug
Type: A Historic Review in US$ Million for 2009-2017
Table 54: Russian Osteoporosis Therapeutics Market Share
Breakdown by Drug Type: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 55: Rest of Europe Osteoporosis Therapeutics Market
Estimates and Forecasts in US$ Million by Drug Type: 2018-2025
Table 56: Osteoporosis Therapeutics Market in Rest of Europe in
US$ Million by Drug Type: A Historic Review for the Period
2009-2017
Table 57: Rest of Europe Osteoporosis Therapeutics Market Share
Breakdown by Drug Type: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 58: Asia-Pacific Osteoporosis Therapeutics Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 59: Osteoporosis Therapeutics Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2009-2017
Table 60: Asia-Pacific Osteoporosis Therapeutics Market Share
Analysis by Region/Country: 2009 VS 2019 VS 2025
Table 61: Osteoporosis Therapeutics Market in Asia-Pacific by
Drug Type: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 62: Asia-Pacific Osteoporosis Therapeutics Historic
Market Scenario in US$ Million by Drug Type: 2009-2017
Table 63: Asia-Pacific Osteoporosis Therapeutics Market Share
Analysis by Drug Type: 2009 VS 2019 VS 2025
AUSTRALIA
Table 64: Osteoporosis Therapeutics Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by Drug Type
for the Period 2018-2025
Table 65: Australian Osteoporosis Therapeutics Historic Market
Analysis in US$ Million by Drug Type: 2009-2017
Table 66: Australian Osteoporosis Therapeutics Market Share
Breakdown by Drug Type: 2009 VS 2019 VS 2025
INDIA
Table 67: Indian Osteoporosis Therapeutics Market Estimates and
Forecasts in US$ Million by Drug Type: 2018 to 2025
Table 68: Indian Osteoporosis Therapeutics Historic Market
Review by Drug Type in US$ Million: 2009-2017
Table 69: Osteoporosis Therapeutics Market in India: Percentage
Share Breakdown of Sales by Drug Type for 2009, 2019, and 2025
SOUTH KOREA
Table 70: Osteoporosis Therapeutics Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by Drug
Type for the Period 2018-2025
Table 71: South Korean Osteoporosis Therapeutics Historic
Market Analysis in US$ Million by Drug Type: 2009-2017
Table 72: Osteoporosis Therapeutics Market Share Distribution
in South Korea by Drug Type: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 73: Rest of Asia-Pacific Market for Osteoporosis
Therapeutics: Annual Sales Estimates and Projections in US$
Million by Drug Type for the Period 2018-2025
Table 74: Osteoporosis Therapeutics Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Drug
Type for the Period 2009-2017
Table 75: Rest of Asia-Pacific Osteoporosis Therapeutics Market
Share Analysis by Drug Type: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 76: Latin American Osteoporosis Therapeutics Market
Trends by Region/Country in US$ Million: 2018-2025
Table 77: Osteoporosis Therapeutics Market in Latin America in
US$ Million by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 78: Latin American Osteoporosis Therapeutics Market
Percentage Breakdown of Sales by Region/Country: 2009, 2019,
and 2025
Table 79: Latin American Osteoporosis Therapeutics Market
Growth Prospects in US$ Million by Drug Type for the Period
2018-2025
Table 80: Osteoporosis Therapeutics Historic Market Analysis in
Latin America in US$ Million by Drug Type: 2009-2017
Table 81: Latin American Osteoporosis Therapeutics Market by
Drug Type: Percentage Breakdown of Sales for 2009, 2019, and
2025
ARGENTINA
Table 82: Argentinean Osteoporosis Therapeutics Market
Estimates and Forecasts in US$ Million by Drug Type: 2018-2025
Table 83: Osteoporosis Therapeutics Market in Argentina in US$
Million by Drug Type: A Historic Review for the Period
2009-2017
Table 84: Argentinean Osteoporosis Therapeutics Market Share
Breakdown by Drug Type: 2009 VS 2019 VS 2025
BRAZIL
Table 85: Osteoporosis Therapeutics Market in Brazil by Drug
Type: Estimates and Projections in US$ Million for the Period
2018-2025
Table 86: Brazilian Osteoporosis Therapeutics Historic Market
Scenario in US$ Million by Drug Type: 2009-2017
Table 87: Brazilian Osteoporosis Therapeutics Market Share
Analysis by Drug Type: 2009 VS 2019 VS 2025
MEXICO
Table 88: Osteoporosis Therapeutics Market in Mexico: Recent
Past, Current and Future Analysis in US$ Million by Drug Type
for the Period 2018-2025
Table 89: Mexican Osteoporosis Therapeutics Historic Market
Analysis in US$ Million by Drug Type: 2009-2017
Table 90: Mexican Osteoporosis Therapeutics Market Share
Breakdown by Drug Type: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 91: Rest of Latin America Osteoporosis Therapeutics
Market Estimates and Projections in US$ Million by Drug Type:
2018 to 2025
Table 92: Osteoporosis Therapeutics Market in Rest of Latin
America by Drug Type: A Historic Review in US$ Million for
2009-2017
Table 93: Rest of Latin America Osteoporosis Therapeutics
Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 94: The Middle East Osteoporosis Therapeutics Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 95: Osteoporosis Therapeutics Market in the Middle East
by Region/Country in US$ Million: 2009-2017
Table 96: The Middle East Osteoporosis Therapeutics Market
Share Breakdown by Region/Country: 2009, 2019, and 2025
Table 97: The Middle East Osteoporosis Therapeutics Market
Estimates and Forecasts in US$ Million by Drug Type: 2018 to
2025
Table 98: The Middle East Osteoporosis Therapeutics Historic
Market by Drug Type in US$ Million: 2009-2017
Table 99: Osteoporosis Therapeutics Market in the Middle East:
Percentage Share Breakdown of Sales by Drug Type for 2009,
2019, and 2025
IRAN
Table 100: Iranian Market for Osteoporosis Therapeutics: Annual
Sales Estimates and Projections in US$ Million by Drug Type for
the Period 2018-2025
Table 101: Osteoporosis Therapeutics Market in Iran: Historic
Sales Analysis in US$ Million by Drug Type for the Period
2009-2017
Table 102: Iranian Osteoporosis Therapeutics Market Share
Analysis by Drug Type: 2009 VS 2019 VS 2025
ISRAEL
Table 103: Israeli Osteoporosis Therapeutics Market Estimates
and Forecasts in US$ Million by Drug Type: 2018-2025
Table 104: Osteoporosis Therapeutics Market in Israel in US$
Million by Drug Type: A Historic Review for the Period
2009-2017
Table 105: Israeli Osteoporosis Therapeutics Market Share
Breakdown by Drug Type: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 106: Saudi Arabian Osteoporosis Therapeutics Market
Growth Prospects in US$ Million by Drug Type for the Period
2018-2025
Table 107: Osteoporosis Therapeutics Historic Market Analysis
in Saudi Arabia in US$ Million by Drug Type: 2009-2017
Table 108: Saudi Arabian Osteoporosis Therapeutics Market by
Drug Type: Percentage Breakdown of Sales for 2009, 2019, and
2025
UNITED ARAB EMIRATES
Table 109: Osteoporosis Therapeutics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Drug Type for the Period 2018-2025
Table 110: United Arab Emirates Osteoporosis Therapeutics
Historic Market Analysis in US$ Million by Drug Type: 2009-2017
Table 111: Osteoporosis Therapeutics Market Share Distribution
in United Arab Emirates by Drug Type: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 112: Osteoporosis Therapeutics Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Million
by Drug Type for the Period 2018-2025
Table 113: Rest of Middle East Osteoporosis Therapeutics
Historic Market Analysis in US$ Million by Drug Type: 2009-2017
Table 114: Rest of Middle East Osteoporosis Therapeutics Market
Share Breakdown by Drug Type: 2009 VS 2019 VS 2025
AFRICA
Table 115: African Osteoporosis Therapeutics Market Estimates
and Projections in US$ Million by Drug Type: 2018 to 2025
Table 116: Osteoporosis Therapeutics Market in Africa by Drug
Type: A Historic Review in US$ Million for 2009-2017
Table 117: African Osteoporosis Therapeutics Market Share
Breakdown by Drug Type: 2009 VS 2019 VS 2025

IV. COMPETITION

ALLERGAN PLC
AMGEN
ELI LILLY AND COMPANY
F. HOFFMANN-LA ROCHE AG
GLAXOSMITHKLINE PLC
MERCK KGAA
NOVARTIS INTERNATIONAL AG
NOVO NORDISK A/S
PFIZER
TEVA PHARMACEUTICAL INDUSTRIES

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05817617/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________